Len Sigal

Leonard Sigal is a Rheumatologist, Clinical Immunologist, and Chief Medical Officer with proven skills in strategies for early development, pharmaceutical study design, and protocol optimization; an innovative thinker and a client-focused advisor. Leonard has taken part in due diligence meetings, as well as advising VC and other groups about the mechanism of molecules under consideration and their potential clinical targets, anticipated usefulness in clinical practice, and expected uptake in the clinical community. He was in academia for 20 years and then worked with big and small pharma while employed by: BMS, NovoNordisk, and PAREXEL. Leonard’s subsequent experience as an independent consultant has allowed him to work in additional molecular types and clinical specialties settings.